SAB Biotherapeutics (SABS) Earnings Date, Estimates & Call Transcripts → Bill Gates is all about this tiny $2 stock (From Timothy Sykes) (Ad) Free SABS Stock Alerts $3.63 -0.24 (-6.20%) (As of 05/17/2024 06:55 PM ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueSABS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.SABS Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs SAB Biotherapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241($0.98)($0.98)($0.98)Q2 20241($1.14)($1.14)($1.14)Q3 20241($1.28)($1.28)($1.28)Q4 20241($1.49)($1.49)($1.49)FY 20244($4.89)($4.89)($4.89) Get SAB Biotherapeutics Earnings AlertsEnter your email address below to receive the latest news and earnings results for SABS and its competitors with MarketBeat's FREE daily newsletter. SABS Earnings Date and InformationSAB Biotherapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 21st, 2024 based off prior year's report dates.Read More SAB Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 5/21/2024Estimated)------- 11/13/2023Q3 2023($0.10)($0.10)-($0.10)-$1.27 million8/21/2023Q2 2023($0.14)($0.14)-($0.14)-$0.09 million5/16/2023Q1 2023($0.08)($0.15)($0.07)($0.15)$5.56 million$0.58 million11/15/2022Q3 2022($0.14)($0.16)($0.02)($0.16)-$3.59 million8/10/2022Q2 2022($0.13)($0.11)+$0.02($0.11)$14.40 million$6.35 million5/12/2022Q1 2022($0.12)($0.15)($0.03)($0.32)$13.20 million$11.80 million Get the Latest News and Ratings for SABS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/22/2021Q3 2021($0.06)($0.02)+$0.04($0.02)-- SAB Biotherapeutics Earnings - Frequently Asked Questions When is SAB Biotherapeutics's earnings date? SAB Biotherapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, May 21st, 2024 based off last year's report dates. Learn more on SABS's earnings history. How much revenue does SAB Biotherapeutics generate each year? SAB Biotherapeutics (NASDAQ:SABS) has a recorded annual revenue of $2.24 million. How much profit does SAB Biotherapeutics generate each year? SAB Biotherapeutics (NASDAQ:SABS) has a recorded net income of -$42.19 million. SABS has generated $0.00 earnings per share over the last four quarters. What is SAB Biotherapeutics's EPS forecast for next year? SAB Biotherapeutics's earnings are expected to decrease from ($4.31) per share to ($6.21) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Curis Earnings Sangamo Therapeutics Earnings Achilles Therapeutics Earnings Estrella Immunopharma Earnings MiNK Therapeutics Earnings Quince Therapeutics Earnings Pluri Earnings Brainstorm Cell Therapeutics Earnings Cyclo Therapeutics Earnings Surrozen Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?JD’s Earnings Could Mean Chinese Stocks Making a ComebackHome Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-Turn This page (NASDAQ:SABS) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersDoes this make you sick?Allegiance GoldUrgent Nvidia WarningAltimetryThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SAB Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
